List of Tables
    Table 1. Tuberculosis Vaccines CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Tuberculosis Vaccines Market Trends
    Table 3. Tuberculosis Vaccines Market Drivers
    Table 4. Tuberculosis Vaccines Market Challenges
    Table 5. Tuberculosis Vaccines Market Restraints
    Table 6. Global Tuberculosis Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Tuberculosis Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Tuberculosis Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Tuberculosis Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Tuberculosis Vaccines Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Tuberculosis Vaccines Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Tuberculosis Vaccines Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Tuberculosis Vaccines Sales by Manufacturer, (K Doses), 2017-2022
    Table 14. Global Tuberculosis Vaccines Sales Share by Manufacturer, 2017-2022
    Table 15. Global Tuberculosis Vaccines Price by Manufacturer (2017-2022) & (USD/Dose)
    Table 16. Global Tuberculosis Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Tuberculosis Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Vaccines as of 2021)
    Table 18. Top Players of Tuberculosis Vaccines in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Tuberculosis Vaccines Product Type
    Table 20. Date of International Manufacturers Enter into Tuberculosis Vaccines Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Tuberculosis Vaccines Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Tuberculosis Vaccines Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Tuberculosis Vaccines Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Tuberculosis Vaccines Sales by Players, (K Doses), 2020, 2021 & 2022
    Table 26. United States Tuberculosis Vaccines Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Tuberculosis Vaccines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Tuberculosis Vaccines Sales in Volume by Region (2017-2022) & (K Doses)
    Table 29. Global Tuberculosis Vaccines Sales in Volume Forecast by Region (2023-2028) & (K Doses)
    Table 30. Global Tuberculosis Vaccines Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Tuberculosis Vaccines Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Tuberculosis Vaccines Sales in Volume by Country (2017-2028) & (K Doses)
    Table 33. North America Tuberculosis Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Tuberculosis Vaccines Sales in Volume by Region (2017-2028) & (K Doses)
    Table 35. Asia Pacific Tuberculosis Vaccines Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Tuberculosis Vaccines Sales in Volume by Country (2017-2028) & (K Doses)
    Table 37. Europe Tuberculosis Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Tuberculosis Vaccines Sales in Volume by Country (2017-2028) & (K Doses)
    Table 39. Latin Americaa Tuberculosis Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Tuberculosis Vaccines Sales in Volume by Country (2017-2028) & (K Doses)
    Table 41. Middle East and Africa Tuberculosis Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Sanofi Corporation Information
    Table 43. Sanofi Description and Business Overview
    Table 44. Sanofi Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 45. Sanofi Tuberculosis Vaccines Product
    Table 46. Sanofi Recent Development
    Table 47. Merck Corporation Information
    Table 48. Merck Description and Business Overview
    Table 49. Merck Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 50. Merck Product
    Table 51. Merck Recent Development
    Table 52. Serum Institute of India Corporation Information
    Table 53. Serum Institute of India Description and Business Overview
    Table 54. Serum Institute of India Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 55. Serum Institute of India Product
    Table 56. Serum Institute of India Recent Development
    Table 57. GlaxoSmithKline Corporation Information
    Table 58. GlaxoSmithKline Description and Business Overview
    Table 59. GlaxoSmithKline Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 60. GlaxoSmithKline Product
    Table 61. GlaxoSmithKline Recent Development
    Table 62. Japan BCG Lab Corporation Information
    Table 63. Japan BCG Lab Description and Business Overview
    Table 64. Japan BCG Lab Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 65. Japan BCG Lab Product
    Table 66. Japan BCG Lab Recent Development
    Table 67. IDT Biologics Corporation Information
    Table 68. IDT Biologics Description and Business Overview
    Table 69. IDT Biologics Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 70. IDT Biologics Product
    Table 71. IDT Biologics Recent Development
    Table 72. GreenSignal Bio Pharma Corporation Information
    Table 73. GreenSignal Bio Pharma Description and Business Overview
    Table 74. GreenSignal Bio Pharma Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 75. GreenSignal Bio Pharma Product
    Table 76. GreenSignal Bio Pharma Recent Development
    Table 77. Taj Pharmaceuticals Corporation Information
    Table 78. Taj Pharmaceuticals Description and Business Overview
    Table 79. Taj Pharmaceuticals Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 80. Taj Pharmaceuticals Product
    Table 81. Taj Pharmaceuticals Recent Development
    Table 82. Bavarian Nordic Corporation Information
    Table 83. Bavarian Nordic Description and Business Overview
    Table 84. Bavarian Nordic Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 85. Bavarian Nordic Product
    Table 86. Bavarian Nordic Recent Development
    Table 87. China National Biotec Group Corporation Information
    Table 88. China National Biotec Group Description and Business Overview
    Table 89. China National Biotec Group Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 90. China National Biotec Group Product
    Table 91. China National Biotec Group Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Tuberculosis Vaccines Customers List
    Table 95. Tuberculosis Vaccines Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Tuberculosis Vaccines Product Picture
    Figure 2. Global Tuberculosis Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Tuberculosis Vaccines Market Size 2017-2028 (US$ Million)
    Figure 4. Global Tuberculosis Vaccines Sales 2017-2028 (K Doses)
    Figure 5. United States Tuberculosis Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Tuberculosis Vaccines Market Size 2017-2028 (US$ Million)
    Figure 7. United States Tuberculosis Vaccines Sales 2017-2028 (K Doses)
    Figure 8. United States Tuberculosis Vaccines Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Tuberculosis Vaccines Market Share in Global, in Volume (K Doses) 2017-2028
    Figure 10. Tuberculosis Vaccines Report Years Considered
    Figure 11. Product Picture of Immunotherapeutic Vaccines
    Figure 12. Product Picture of Booster Vaccines
    Figure 13. Product Picture of Others
    Figure 14. Global Tuberculosis Vaccines Market Share by Type in 2022 & 2028
    Figure 15. Global Tuberculosis Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Tuberculosis Vaccines Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Tuberculosis Vaccines Sales by Type (2017-2028) & (K Doses)
    Figure 18. Global Tuberculosis Vaccines Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Tuberculosis Vaccines Price by Type (2017-2028) & (USD/Dose)
    Figure 20. United States Tuberculosis Vaccines Market Share by Type in 2022 & 2028
    Figure 21. United States Tuberculosis Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Tuberculosis Vaccines Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Tuberculosis Vaccines Sales by Type (2017-2028) & (K Doses)
    Figure 24. United States Tuberculosis Vaccines Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Tuberculosis Vaccines Price by Type (2017-2028) & (USD/Dose)
    Figure 26. Product Picture of Hospitals
    Figure 27. Product Picture of Clinics
    Figure 28. Product Picture of Others
    Figure 29. Global Tuberculosis Vaccines Market Share by Application in 2022 & 2028
    Figure 30. Global Tuberculosis Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Tuberculosis Vaccines Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Tuberculosis Vaccines Sales by Application (2017-2028) & (K Doses)
    Figure 33. Global Tuberculosis Vaccines Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Tuberculosis Vaccines Price by Application (2017-2028) & (USD/Dose)
    Figure 35. United States Tuberculosis Vaccines Market Share by Application in 2022 & 2028
    Figure 36. United States Tuberculosis Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Tuberculosis Vaccines Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Tuberculosis Vaccines Sales by Application (2017-2028) & (K Doses)
    Figure 39. United States Tuberculosis Vaccines Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Tuberculosis Vaccines Price by Application (2017-2028) & (USD/Dose)
    Figure 41. North America Tuberculosis Vaccines Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 42. North America Tuberculosis Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Tuberculosis Vaccines Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 46. Europe Tuberculosis Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Tuberculosis Vaccines Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 53. Asia-Pacific Tuberculosis Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Tuberculosis Vaccines Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 65. Latin America Tuberculosis Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Tuberculosis Vaccines Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 70. Middle East & Africa Tuberculosis Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. UAE Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Tuberculosis Vaccines Value Chain
    Figure 75. Tuberculosis Vaccines Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed